alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2
IEA Income Fund X
Rule 13a-14 CERTIFICATIONS
     I, John Kallas, certify that:
     1. I have reviewed this annual report on Form 10-K of IEA Income Fund X(the “Registrant”);
     2. Based on my knowledge, this annual report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this annualreport;
     3. Based on my knowledge, the financial statements, and other financialinformation included in this annual report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theRegistrant as of, and for, the periods presented in this annual report;
     4. The other certifying officer of Cronos Capital Corp. (“CCC”), theGeneral Partner of the Registrant, and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-14 and 15d-14) for the Registrant and we have:
          (a) designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the Registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this quarterly report is beingprepared; and
          (b) evaluated the effectiveness of the Registrant’s disclosure controlsand procedures and presented in this annual report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and
          (c) disclosed in this report any change in the Registrant’s internalcontrol over financial reporting that occurred during the Registrant’s mostrecent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the Registrant’s internal control over financial reporting.
     5. CCC’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theRegistrant’s auditors and the Audit Committee of Registrant’s Board ofDirectors (or persons performing the equivalent function):
          (a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the Registrant’s ability to record, process,summarize and report financial information; and
          (b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the Registrant’s internal control overfinancial reporting.
Date: March 26, 2004
/s/ JOHN KALLASJohn KallasChief Financial Officer of CCC
<PAGE>
 
                                   EXHIBIT 11

              AMERICAN BUSINESS INFORMATION, INC. AND SUBSIDIARIES
             STATEMENT REGARDING COMPUTATION OF PER SHARE EARNINGS
               For the three months ended March 31, 1997 and 1996
                    (In thousands, except per share amounts)
<TABLE>
<CAPTION>                         
 
 

                                                  Three Months Ended
                                                      March 31
                                                  ------------------ 
                                                    1997       1996
                                                    ----       ----
 
<S>                                                 <C>       <C> 
Average shares outstanding......................    23,206    20,783            
Net additional common equivalent shares.........       107       137
                                                  --------   -------
 
Average number of common and common equivalent
 shares outstanding.............................    23,313    20,920
                                                  ========   =======
 
Net income for per share computation............  $(47,196)  $ 4,709
                                                  ========   =======
 
Net income per average common and common
  equivalent share outstanding..................  $  (2.02)  $  0.23
                                                  ========   =======
 
</TABLE>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 582 Introduced in House (IH)]

<DOC>

114th CONGRESS
  2d Session
H. RES. 582

            Condemning and censuring President Barack Obama.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 7, 2016

 Mr. Palazzo (for himself, Mr. Cole, Mr. Collins of Georgia, Mr. Yoho, 
 Mr. Abraham, Mr. Westerman, Mr. DesJarlais, Mr. Fincher, Mr. Rouzer, 
    Mr. Hunter, Mr. Stewart, Mr. Jody B. Hice of Georgia, and Mrs. 
 Blackburn) submitted the following resolution; which was referred to 
                     the Committee on the Judiciary

_______________________________________________________________________

                               RESOLUTION

 
            Condemning and censuring President Barack Obama.

Whereas upon entering the Execution of the Office of President of the United 
        States, President Barack Obama affirmed his constitutional oath as 
        follows: ``I do solemnly swear that I will faithfully execute the Office 
        of President of the United States, and will to the best of my Ability, 
        preserve, protect and defend the Constitution of the United States'';
Whereas President Barack Obama has failed to faithfully execute the Office of 
        the President of the United States and has failed to preserve, protect 
        and defend the Constitution of the United States;
Whereas President Barack Obama has failed to fulfill his duty in article II, 
        section 3 of the Constitution of the United States that he ``shall take 
        Care that the Laws be faithfully executed'';
Whereas the Constitution of the United States in article I, section 1 provides 
        that ``All legislative Powers herein granted shall be vested in a 
        Congress of the United States'';
Whereas the Second Amendment to the Constitution of the United States provides 
        that ``the right of the people to keep and bear Arms, shall not be 
        infringed''; and
Whereas, on January 5, 2016, President Barack Obama defied article I, section 1 
        of the Constitution of the United States by implementing 
        unconstitutional executive actions without congressional consideration, 
        debate, or approval in order to infringe on the Second Amendment right 
        of the American people to keep and bear arms: Now, therefore, be it
    Resolved, That the House of Representatives does hereby censure and 
condemn Barack Obama for having willfully disregarded the legislative 
powers of the duly elected Congress provided by the Constitution of the 
United States through his executive actions to deprive American 
citizens of their constitutionally mandated right to bear arms under 
the Second Amendment.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> CT
<CIK> 0000879555
<NAME> BOSTON CAPITAL TAX CREDIT FUND III LP
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               DEC-31-1998
<TOTAL-ASSETS>                               120806543
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 120806543
<TOTAL-REVENUES>                                183145
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (12229726)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (12046581)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit








Exhibit 10.1
        
Amendment to
CF Industries Holdings, Inc.
2005 Equity and Incentive Plan
WHEREAS, the Board of Directors (the “Board”) of CF Industries Holdings, Inc. (the “Company”) has determined that it is in the best interest of the Company that the CF Industries Holdings, Inc. 2005 Equity and Incentive Plan (the “Plan”) be amended to revise the tax withholding provisions set forth in Section 8(c) of the Plan; and


WHEREAS, the Board has the authority under Section 8(d)(ii) of the Plan to amend the Plan. 


NOW, THEREFORE, pursuant to Section 8(d)(ii) thereof, the Plan is hereby amended as set forth below. 


1.    Section 8(c) of the Plan is amended in its entirety to read as follows: 


(c)    Taxes. The Company or any Subsidiary of the Company is authorized to withhold from any Award granted, any payment relating to an Award under the Plan, including from a distribution of Stock, or any other payment to a Grantee, amounts of withholding and other taxes due in connection with any transaction involving an Award, and to take such other action as the Committee may deem advisable to enable the Company and Grantees to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award. This authority shall include authority to withhold or receive Stock or other property and to make cash payments in respect thereof in satisfaction of a Grantee’s tax obligations. The Committee may provide in the Award Agreement that in the event that a Grantee is required to pay any amount to be withheld in connection with the issuance of shares of Stock in settlement or exercise of an Award, the Grantee shall or may satisfy such obligation (in whole or in part) by electing to have withheld a portion of the shares of Stock otherwise to be received upon settlement or exercise of such Award equal to an amount no greater than the maximum statutory tax rate applicable to such Grantee in all relevant jurisdictions and in all cases reduced by the amount of any withholding obligation a Grantee satisfies by cash payment to the Company. All Awards made under the Plan are intended to be exempt from, or to comply with, the requirements of Section 409A of the Code and any regulations or guidance promulgated thereunder and the Plan and such Awards shall be interpreted in a manner consistent with such interpretation.


2.    Effect on Plan.  Except as expressly amended hereby, the Plan shall remain in full force and effect.


3.     Effective Date.  The effective date of this Amendment to the Plan shall be July 11, 2018.











IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by a duly authorized representative of the Company, effective as of the Effective Date. 
CF INDUSTRIES HOLDINGS, INC.


	
		
	By:
	/s/ Douglas C. Barnard

	Name:
	Douglas C. Barnard

	Title:
	Senior Vice President, General

	 
	Counsel, and Secretary
dxlg-ex101_6.htm



 

Exhibit 10.1

SECOND AMENDMENT to TRANSITION AGREEMENT

This Second Amendment to Transition Agreement (the “Second Amendment”) is made as of this 31 day of July, 2018 (the “Execution Date”) by and between Destination XL Group, Inc., a Delaware corporation (“Company”), and David A. Levin, an individual (“Executive”).  The terms “Party” or “Parties” shall be used to refer to the Company and/or Executive.  Capitalized terms not defined herein shall have the meaning ascribed in the Employment Agreement (defined below).

WHEREAS, the Company and Executive are parties to that certain Transition Agreement dated as of March 20, 2018 (the “Transition Agreement”);

WHEREAS, the Transition Agreement was amended on June 25, 2018 by the execution the First Amendment to the Transition Agreement;

WHEREAS, the Company and Executive have agreed to amend the Transition Agreement to change the determination of the Executive’s AIP Bonus and LTIP award for the fiscal year ending February 1, 2020 if the Executive remains employed through December 31, 2019; and

NOW, THEREFORE, for and in consideration of the promises and the consideration more fully set forth herein and in the Transition Agreement, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound hereby, the Company and Executive mutually agree as follows:

1.Paragraph 1(e) of the Transition Agreement is deleted in its entirety and replaced with the following:

(e)With respect to Executive’s ongoing employment through to December 31, 2019 (including with respect to Executive’s services during the Transition Period), Executive’s AIP Bonus and LTIP award with regard to the fiscal years ending February 2, 2019 and February 1, 2020 will be earned on the basis of performance metrics determined by the Compensation Committee for such years. 

2.The parties acknowledge that good and valuable consideration supports this Second Amendment.

3.Except as otherwise modified hereby, the terms and conditions of the Transition Agreement are hereby ratified, approved and confirmed as of the date hereof and shall remain in full force and effect.

4.This Second Amendment supersedes all prior communications between the parties hereto with respect to the subject matter hereof and shall be binding upon and inure to the benefit of the parties, their respective successors and assigns.  

5.This Second Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which shall constitute one agreement.  

[SIGNATURE PAGE FOLLOWS]




 

 

IN WITNESS WHEREOF, and intending to be legally bound hereby, the Parties hereby execute this Second Amendment as of the first date set forth below.

 


		
	
DATED: July 31, 2018
	
Destination XL Group, Inc.  

By:__/s/ Willem Mesdag  

Its: Director and Chairman, 

Compensation Committee 

 

 

	
DATED:  July 31, 2018
	
By:  __/s/ David A. Levin

                David A. Levin
August 28, 1996

19422

#### State v. Ross

Affirmed
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Veterinary Biologics

Last Modified: 

Print

APHIS regulates veterinary biologics (vaccines, bacterins, antisera, diagnostic kits,

and other products of biological origin) to ensure that the veterinary biologics

available for the diagnosis, prevention, and treatment of animal diseases are pure,

safe, potent, and effective. 

This work is done by APHIS' Center for Veterinary Biologics (CVB) and is centered

around enforcement of the Virus Serum Toxin Act (16.44 KB). For more information,

visit Common Questions About Veterinary Biologics.

Learn More About the CVB

Hear What Employees Say About the CVB in This Video

Licensed Veterinary Biological Product Information 

View the list of biologics that are currently licensed by APHIS as well as licensing

data for those products.

Learn More

Adverse Event Reporting Program 

Report adverse events experienced when using biologics, and learn about APHIS'

role in these scenarios.
Learn More

NCAH Portal Guidance for CVB Submitters 

Find information and guidance on the NCAH Portal as it applies to CVB.

Learn More

Licensing a Biologic: Suggestions for New Applicants 

Learn how to get started on the regulatory path toward licensure.

Learn More

Importing Biologics 

Learn about importing biologics for experimental use or distribution/sale.

Learn More

Exporting Biologics 

Learn how CVB facilitates the export of licensed biologicals.

Learn More

More Resources

Newly Published Information 

View veterinary biologics information published in the last 90 days.

Biologics Regulations and Guidance 

View regulations, guidance documents (including draft guidance for public

comment), and standardized assay methods pertaining to the licensure of veterinary

biologics.

Biologics Forms 

Find APHIS forms for veterinary biologics.

Other Biologics Activities 

The CVB participates in national and international animal health and regulatory

organizations. Learn about CVB activities.
Biologics Program Links 

View links to other sites associated with regulation and international harmonization.

Freedom of Information Act 

Request biologics information via the Freedom of Information Act (FOIA).

Have a question or comment about the CVB web pages?

Contact us if you need help with a broken link, a page loading incorrectly, or other

technical problems. Please provide the URL (address) of the page. You can report

these problems or let us know what you think about our web pages by emailing the

CVB web content manager.
<PAGE>
                                                                    Exhibit 32.2


    CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report on Form 10-Q of Insurance Auto
Auctions, Inc. (the "Company") for the quarterly period ended September 25, 2005
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Scott P. Pettit, Chief Financial Officer of the Company, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)   the Report fully complies with the requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

         (2)   the information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.


Date:  November 9, 2005
                                        /s/ Scott P. Pettit
                                        ----------------------------------------
                                        Scott P. Pettit, Chief Financial Officer


         This certification accompanies this Report pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

         A signed original of this written statement required by Section 906 has
been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<PAGE>
 
 <ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                      12,042,656
<INT-BEARING-DEPOSITS>                       9,000,000
<FED-FUNDS-SOLD>                               100,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 22,232,193
<INVESTMENTS-CARRYING>                      96,726,545
<INVESTMENTS-MARKET>                        96,099,285
<LOANS>                                    210,205,393
<ALLOWANCE>                                  2,800,000
<TOTAL-ASSETS>                             362,910,478
<DEPOSITS>                                 300,785,420
<SHORT-TERM>                                 3,876,194
<LIABILITIES-OTHER>                          4,739,903
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        34,500
<OTHER-SE>                                  53,474,461
<TOTAL-LIABILITIES-AND-EQUITY>             362,910,478
<INTEREST-LOAN>                             19,191,106
<INTEREST-INVEST>                            8,229,172
<INTEREST-OTHER>                               614,239
<INTEREST-TOTAL>                            28,034,517
<INTEREST-DEPOSIT>                          11,174,695
<INTEREST-EXPENSE>                          11,380,632
<INTEREST-INCOME-NET>                       16,653,885
<LOAN-LOSSES>                                  644,466
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                             12,535,873
<INCOME-PRETAX>                              4,123,351
<INCOME-PRE-EXTRAORDINARY>                   4,123,351
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,964,868
<EPS-PRIMARY>                                      .90
<EPS-DILUTED>                                      .90
<YIELD-ACTUAL>                                    8.10
<LOANS-NON>                                  6,927,000
<LOANS-PAST>                                 3,565,000
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                              1,450,737
<ALLOWANCE-OPEN>                             2,725,000
<CHARGE-OFFS>                                  638,372
<RECOVERIES>                                    68,906
<ALLOWANCE-CLOSE>                            2,800,000
<ALLOWANCE-DOMESTIC>                           840,000
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                      1,960,000
        

</TABLE>
Bureau of Labor Statistics

Series Id:

Series title:

Labor force status:

Type of data:

Age:

Years:

Year Qtr1 Qtr2 Qtr3 Qtr4 Annual

2011 12753

Employed part time (persons who usually work 

Number in thousands

25 to 54 years

2011 to 2011

Labor Force Statistics from the Current Population Survey

Original Data Value

LNU02600060Q

Not Seasonally Adjusted

(Unadj) Employed, Usually Work Part Time - 25-

Source: Bureau of Labor Statistics Generated on: May 16, 2011 (02:08:36 PM)
# C_2018311EN.01000801.xml

| 3.9.2018 | EN | Official Journal of the European Union | C 311/8 |
| --- | --- | --- | --- |

3.9.2018

EN

Official Journal of the European Union

C 311/8

---

Request for a preliminary ruling from the Arbeidsrechtbank Antwerpen (Belgium) lodged on 19 June 2018 — Jamina Hakelbracht, Tine Vandenbon, Instituut voor de Gelijkheid van Vrouwen en Mannen v WTG Retail BVBA

(Case C-404/18)

(2018/C 311/07)

Language of the case: Dutch

Referring court

Arbeidsrechtbank Antwerpen

Parties to the main proceedings

Applicants: Jamina Hakelbracht, Tine Vandenbon, Instituut voor de Gelijkheid van Vrouwen en Mannen

Defendant: WTG Retail BVBA

Question referred

Should European Union law and, more specifically, Article 24 of Directive 2006/54/EC (1) of the European Parliament and of the Council of 5 July 2006 on the implementation of the principle of equal opportunities and equal treatment of men and women in matters of employment and occupation, be interpreted as precluding national legislation which affords protection against retaliation to persons who act as witnesses only to persons who, in the context of the investigation of a complaint, bring to the notice of the person with whom the complaint is lodged, in a signed and dated document, the facts which they have personally seen or heard and which relate to the situation which is the subject of the complaint filed or who appear as witnesses in legal proceedings?

---

(1)  OJ 2006 L 204, p. 23.

---
Exhibit 23










               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS




We consent to the incorporation by reference in the Registration Statement (Form
S-8 No.  333-63109 and Form S-8 No.  333-72101)  pertaining to the RSI Holdings,
Inc. Stock Option Plan  (Amendment Nos. 3 and 4) of our report dated October 31,
2002,  with respect to the  consolidated  financial  statements of RSI Holdings,
Inc.  included in the Annual  Report (Form 10-KSB) for the year ended August 31,
2002.





                                   /s/  Elliott Davis, LLC



November 27, 2002
Greenville, South Carolina